-
Product Insights
New![]()
Bomen Solar Farm
Bomen Solar Farm is a solar PV project located in New South Wales, Australia. The project is owned by Spark Infrastructure Group and was developed by Renew Estate. The project came online in 2020. Empower your strategies with our Bomen Solar Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
New![]()
Sunny Shores Green Energy Solar Park
Sunny Shores Green Energy Solar Park is a solar PV project located in Ontario, Canada. The project was developed by Spark Solar Australia Propriety Limited. The project came online in 2014. Empower your strategies with our Sunny Shores Green Energy Solar Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
NewWettle Creek Energy Hub Wind Farm
Wettle Creek Energy Hub Wind Farm is an Onshore Wind project located in New South Wales, Australia. The project is owned and being developed by Spark Renewables Pty Ltd. The project is expected to come online in 2027. Empower your strategies with our Wettle Creek Energy Hub Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
New![]()
Sea Fern Floating Offshore Wind Project
Sea Fern Floating Offshore Wind Project is an offshore wind project located in Tasman Sea, Australia. The project is owned and being developed by Simply Blue Group; Spark Renewables Pty Ltd; Subsea 7 SA. The project is expected to come online in 2060. Empower your strategies with our Sea Fern Floating Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dirloctocogene Samoparvovec in Hemophilia A (Factor VIII Deficiency)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Dirloctocogene Samoparvovec in Hemophilia A (Factor VIII Deficiency) Drug Details:RG-6357 (SPK-8011, SPK-FVIII) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – EU-101 in Non-Small Cell Lung Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EU-101 in Non-Small Cell Lung Cancer Drug Details: EU-101 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Prp in Gastrointestinal Tract Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PRP in Gastrointestinal Tract Cancer Drug Details:PRP is under development for the treatment of solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Zanidatamab in Adenocarcinoma Of The Gastroesophageal Junction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Zanidatamab in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:Zanidatamab is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Pirtobrutinib in Diffuse Large B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pirtobrutinib in Diffuse Large B-Cell Lymphoma Drug Details: Pirtobrutinib (Jaypirca) is an anti-neoplastic agent. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Curcumin + Doxorubicin) in Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. (Curcumin + Doxorubicin) in Colorectal Cancer Drug Details: Imx-110 is under development for the treatment...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.